Orbimed Advisors - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 96 filers reported holding RAPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,690,986
-11.6%
1,244,945
-0.5%
0.44%
+3.8%
Q2 2023$23,395,009
+1.9%
1,251,0700.0%0.42%
-6.0%
Q1 2023$22,957,135
-7.3%
1,251,0700.0%0.45%
-4.9%
Q4 2022$24,771,186
-17.7%
1,251,0700.0%0.47%
-15.2%
Q3 2022$30,101,000
+90.4%
1,251,070
+44.4%
0.56%
+94.8%
Q2 2022$15,812,000
+99.0%
866,396
+139.8%
0.29%
+122.5%
Q1 2022$7,945,000
-0.3%
361,300
+66.5%
0.13%
+26.5%
Q4 2021$7,970,000217,0000.10%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Ponoi Management, LLC 1,599,417$31,588,00018.07%
KPCB XV Associates, LLC 1,947,063$38,454,00016.52%
Column Group LLC 3,885,679$76,742,0006.96%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,122,237$22,164,0003.20%
Euclidean Capital LLC 735,801$14,532,0003.08%
Ponoi II Management, LLC 145,401$2,872,0002.09%
Trustees of Columbia University in the City of New York 73,383$1,449,0001.94%
ACUTA CAPITAL PARTNERS, LLC 209,600$4,140,0001.13%
AJU IB Investment Co., Ltd. 108,503$2,143,0000.81%
Alphabet Inc. 831,254$16,417,0000.79%
View complete list of RAPT THERAPEUTICS INC shareholders